Skip to main content
Equibles
VTRS logo

VTRS · Viatris Inc

Track VTRS — free

Use VTRS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$16.88 -0.06 (-0.35%) At close · Sep 4
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$19.46B
Shares
1.15B

VTRS metrics

81 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$16.88
Market cap
$19.46B

Price action

19 metrics
Price change (1W)
+0.3%
Price change (30D)
+4.0%
Price change (3M)
+6.5%
Price change (6M)
+16.6%
Price change (YTD)
+36.1%
Price change (1Y)
+60.6%
Trailing year
Price change (5Y)
+13.8%
52-week high
$17.86
52-week low
$9.49
Change from 52-week high
-5.2%
Change from 52-week low
+78.5%
Annualized volatility
32.2%
Beta
0.7
RSI (14D)
55.1
Price vs SMA 50
+1.1%
Price vs SMA 200
+15.3%
Avg volume (3M)
9.68M
Relative volume
0.8
Average dollar volume
$159.95M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
1.15B

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.2×
reciprocal yield 46.2%
EV / EBITDA
11.8×
reciprocal yield 8.5%
EV / EBIT
—
P / sales
1.3×
reciprocal yield 75.7%
P / book
1.4
reciprocal yield 73.3%
FCF yield
10.0%
TTM · current market cap
Buyback yield
1.5%
P / FCF
10.0
reciprocal yield 10.0%
P / operating cash flow
8.3
reciprocal yield 12.0%
Earnings yield
-3.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
2.8%
Trailing 12 months
Payout ratio
—
Shareholder yield
1.5%
Dividend / share (TTM)
$0.48
Dividend growth YoY
+0.0%
Dividend growth streak
—
Last ex-dividend
2026-08-21

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
34.8%
Operating margin
-0.6%
Trailing 12 months
Net margin
-24.6%
Gross profit (TTM)
$5.13B
Operating profit (TTM)
−$87.30M
Net income (TTM)
−$669.90M
Trailing 12 months
Diluted EPS (TTM)
$-0.40
FCF margin
13.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+4.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$14.74B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-0.8%
Year over year · fewer shares
Revenue CAGR (3Y)
-4.2%
Revenue CAGR (5Y)
+3.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-9.3%
FCF CAGR (5Y)
+14.4%

Quality

14 metrics
Return on equity
-2.9%
Return on assets
-1.1%
Debt / equity
0.9
Current ratio
1.6
EBITDA (TTM)
$2.72B
Free cash flow (TTM)
$1.95B
Quick ratio
1.0
Interest coverage
-0.2
Net debt / EBITDA
4.6
Return on invested capital
—
Trailing 12 months
Net cash
−$12.46B
Latest balance sheet
Cash & equivalents
$886.50M
Total assets
$35.04B
Total debt
$13.35B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.33B
Capital expenditures (TTM)
$376.00M
R&D (TTM)
$1.02B
SG&A (TTM)
$3.98B
Stock compensation (TTM)
$172.30M
R&D / revenue
6.9%
Stock compensation / revenue
1.2%

Ownership (13F)

3 metrics
13F filers
1,030
13F filer change QoQ
-2
Institutional ownership
92.2%

Short interest

3 metrics
Short interest
3.2%
Latest settlement · 3.0 days to cover
Days to cover
3.0d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$809,784
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1792044 CUSIP 92556V106 13F (30d) 608 filings 561 filers Visit website Investor relations